Wellington Management Group
PVLA

Wellington Management Group’s Palvella Therapeutics PVLA Stock Holding History

Wellington Management Group’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.24M Buy
34,040
+11,637
+52% +$1.21M ﹤0.01% 1431
2025
Q4 		$2.34M Sell
22,403
-1,299
-5% -$111K ﹤0.01% 1562
2025
Q3 		$1.49M Buy
+23,702
New +$1.06M ﹤0.01% 1709
2018
Q4 		– Sell
-1,109
Closed -$497K – 2230
2018
Q3 		$497K Hold
1,109
– – ﹤0.01% 2040
2018
Q2 		$450K Hold
1,109
– – ﹤0.01% 2071
2018
Q1 		$605K Buy
1,109
+138
+14% +$85.4K ﹤0.01% 1990
2017
Q4 		$586K Hold
971
– – ﹤0.01% 2013
2017
Q3 		$447K Buy
+971
New +$415K ﹤0.01% 2062

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group's PVLA Position: Q1 2026 in Review

Wellington Management Group increased its Palvella Therapeutics (PVLA) stake by 52% in Q1 2026, buying an estimated $1.21M and bringing the position to 34,040 shares worth $4.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1431.

Wellington Management Group first reported a position in PVLA in Q3 2017 and has held it in 8 quarters since. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.

  • Wellington Management Group held 34,040 shares of Palvella Therapeutics worth $4.24M as of Q1 2026.
  • Wellington Management Group bought 11,637 Palvella Therapeutics shares in Q1 2026, an estimated $1.21M.
  • Palvella Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1431 holding.
  • Wellington Management Group first reported a position in Palvella Therapeutics in Q3 2017 and has held it in 8 quarters since.
  • 180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.